Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Other Accumulated Expenses (2020 - 2023)

Sight Sciences has reported Other Accumulated Expenses over the past 4 years, most recently at $1.5 million for Q3 2023.

  • Quarterly results put Other Accumulated Expenses at $1.5 million for Q3 2023, up 56.71% from a year ago — trailing twelve months through Sep 2023 was $1.5 million (up 56.71% YoY), and the annual figure for FY2022 was $1.1 million, up 65.95%.
  • Other Accumulated Expenses for Q3 2023 was $1.5 million at Sight Sciences, up from $1.3 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for SGHT hit a ceiling of $1.5 million in Q3 2023 and a floor of $446000.0 in Q4 2020.
  • Median Other Accumulated Expenses over the past 4 years was $839000.0 (2022), compared with a mean of $843636.4.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 83.99% in 2022 and later grew 20.38% in 2023.
  • Sight Sciences' Other Accumulated Expenses stood at $446000.0 in 2020, then surged by 46.86% to $655000.0 in 2021, then surged by 65.95% to $1.1 million in 2022, then soared by 34.22% to $1.5 million in 2023.
  • The last three reported values for Other Accumulated Expenses were $1.5 million (Q3 2023), $1.3 million (Q2 2023), and $892000.0 (Q1 2023) per Business Quant data.